Evidence map›Paper›PMID 42093794›Full record

ArticleCureus2026

Extreme Left Ventricular Hypertrophy in Pediatric Hypertrophic Obstructive Cardiomyopathy.

Elma Smajlović, Alma Bolic Alic

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elma SmajlovićDepartment of Pediatrics, Cantonal Hospital Zenica, Zenica, BIH.
Alma Bolic AlicDepartment of Pediatrics, Cantonal Hospital Zenica, Zenica, BIH.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertrophic cardiomyopathy (HCM) in childhood is characterized by marked phenotypic heterogeneity and poses significant challenges in risk stratification for sudden cardiac death (SCD). We report the case of a 9.5-year-old girl in whom transthoracic echocardiography revealed progressive extreme interventricular septal hypertrophy (up to 33 mm; Z-score > +11), marked left atrial enlargement, reduced left ventricular cavity size, and significant left ventricular outflow tract obstruction. Although repeated ambulatory Holter monitoring did not reveal ventricular arrhythmias, the patient exhibited one episode of unexplained syncope at rest. These findings placed her in a high-risk category according to contemporary pediatric risk stratification approaches. Following insufficient response to medical therapy, surgical septal myectomy was performed. Given the persistent high-risk profile, an implantable cardioverter-defibrillator was implanted for primary prevention of sudden cardiac death. This case emphasizes the importance of individualized, multimodal risk stratification in guiding management decisions in pediatric HCM, even in the absence of documented malignant arrhythmias.

Indexed as

hypertrophic cardiomayopathyimplantable cardioverter-defibrillatorseptal myectomysudden cardiac death (scd)ventricular tachycardia (vt)

Identifiers

PMID42093794
PMCPMC13139872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.